Outcome of Anti-GD2 Immunotherapy in Dutch Patients with High-Risk Neuroblastoma

M. Tas; L. Dootjes; M. Fiocco; R. de Krijger; M. Dierselhuis; N. van Eijkelenburg; M. van Grotel; K. Kraal; A. Peek; K. van de Ven; B. de Keizer; A. Littooij; G. Janssens; G. Tytgat; M. van Noesel

Outcome of Anti-GD2 Immunotherapy in Dutch Patients with High-Risk Neuroblastoma

M. Tas, L. Dootjes, M. Fiocco, R. de Krijger, M. Dierselhuis, N. van Eijkelenburg, M. van Grotel, K. Kraal, A. Peek, K. van de Ven, B. de Keizer, A. Littooij, G. Janssens, G. Tytgat, M. van Noesel

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	S341-S342
Journal	Pediatric Blood & Cancer
Volume	66
Publication status	Published - Dec 2019

Cite this

@article{720ea21cccd54b559918ad71ac4a90a5,

title = "Outcome of Anti-GD2 Immunotherapy in Dutch Patients with High-Risk Neuroblastoma",

author = "M. Tas and L. Dootjes and M. Fiocco and {de Krijger}, R. and M. Dierselhuis and {van Eijkelenburg}, N. and {van Grotel}, M. and K. Kraal and A. Peek and {van de Ven}, K. and {de Keizer}, B. and A. Littooij and G. Janssens and G. Tytgat and {van Noesel}, M.",

year = "2019",

month = dec,

language = "English",

volume = "66",

pages = "S341--S342",

journal = "Pediatric Blood & Cancer",

issn = "1545-5009",

publisher = "Wiley-Liss Inc.",

}

TY - JOUR

T1 - Outcome of Anti-GD2 Immunotherapy in Dutch Patients with High-Risk Neuroblastoma

AU - Tas, M.

AU - Dootjes, L.

AU - Fiocco, M.

AU - de Krijger, R.

AU - Dierselhuis, M.

AU - van Eijkelenburg, N.

AU - van Grotel, M.

AU - Kraal, K.

AU - Peek, A.

AU - van de Ven, K.

AU - de Keizer, B.

AU - Littooij, A.

AU - Janssens, G.

AU - Tytgat, G.

AU - van Noesel, M.

PY - 2019/12

Y1 - 2019/12

M3 - Meeting Abstract

SN - 1545-5009

VL - 66

SP - S341-S342

JO - Pediatric Blood & Cancer

JF - Pediatric Blood & Cancer

ER -